A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity
A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity
Active, not recruiting · NCT03092323 · Registry updated 2023-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity | Soft Tissue Sarcoma of the Extremity | Active, not recruiting | Phase 2 | 2023-11-18 | NCT03092323 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| Sarcoma Alliance for Research through Collaboration | 7 |
| Stand Up To Cancer | 20 |
20 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.